Continuity of Care to Prevent Readmissions for Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

COPD. 2017 Apr;14(2):251-261. doi: 10.1080/15412555.2016.1256384. Epub 2017 Feb 7.

Abstract

Readmissions of patients with chronic obstructive pulmonary disease (COPD) to hospitals cast a heavy burden to health care systems. This meta-analysis was aimed to assess the efficacy of continuity of care as interventions, which reduced readmission and mortality rates of such patients. PubMed, Cochrane Library and Embase were searched for articles published before July 2015. A total of 31 reports with randomized controlled trials (RCTs) were finally included in this meta-analysis. The results showed that health education reduced all-cause readmission at 3 months. In addition, health education, comprehensive nursing intervention (CNI) and telemonitoring reduced all-cause readmissions over 6-12 months, and the effect of CNI was best because CNI also reduced COPD-specific readmissions. Home visits also reduced COPD-specific readmissions (the quality more than moderate), but it did not reduce the risk for all-cause readmissions (risk ratios (RRs), 0.92 [95% CI, 0.82-1.04]; moderate quality). There was no statistically significant difference in reducing mortality and quality of life (QOL) among various continued cares. In conclusion, CNI, telemonitoring, health education and home visits should receive more consideration than other interventions by caregivers seeking to implement continued care interventions for patients with COPD.

Keywords: Chronic obstructive pulmonary disease; continuity of care; interventions; readmissions.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Continuity of Patient Care*
  • Health Education*
  • House Calls*
  • Humans
  • Monitoring, Physiologic / methods
  • Patient Readmission / statistics & numerical data*
  • Pulmonary Disease, Chronic Obstructive / mortality
  • Pulmonary Disease, Chronic Obstructive / nursing*
  • Pulmonary Disease, Chronic Obstructive / physiopathology
  • Quality of Life
  • Randomized Controlled Trials as Topic
  • Telemedicine*